Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

S2k guideline on diagnosis and treatment of atopic dermatitis — short version

S2k guideline on diagnosis and treatment of atopic dermatitis — short version Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org ). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Allergo Journal International Springer Journals

S2k guideline on diagnosis and treatment of atopic dermatitis — short version

Download PDF
14 pages

Loading next page...
 
/lp/springer-journals/s2k-guideline-on-diagnosis-and-treatment-of-atopic-dermatitis-short-lpv4QS0XJp
Publisher
Springer Journals
Copyright
Copyright © 2016 by Springer Medizin
Subject
Medicine & Public Health; Allergology; Dermatology; Environmental Health; Immunology
eISSN
2197-0378
DOI
10.1007/s40629-016-0110-8
Publisher site
See Article on Publisher Site

Abstract

Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org ).

Journal

Allergo Journal International – Springer Journals

Published: May 2, 2016

References

  • [Atopic dermatitis: S2 guidelines]
    Werfel, T.; Aberer, W.; Augustin, M.
  • Study of perceptions of the extent to which guideline recommendations are binding: a survey of commonly used terminology
    Nast, A.; Sporbeck, B.; Jacobs, A.
  • Guidelines for treatment of atopic eczema (atopic dermatitis)
    Ring, J.; Alomar, A.; Bieber, T.
  • Guidelines for treatment of atopic eczema (atopic dermatitis). Part II
    Ring, J.; Alomar, A.; Bieber, T.
  • The diagnosis and graded therapy of atopic dermatitis
    Werfel, T.; Schwerk, N.; Hansen, G.
  • [Significance of atopic dermatitis in outpatient medical care
    Schmitt, J.; Schmitt, N.M.; Kirch, W.
  • Outpatient care and medical treatment of children and adults with atopic eczema
    Schmitt, J.; Schmitt, N.M.; Kirch, W.
  • [Associated diseases and differential diagnostic considerations in childhood atopic eczema]
    Jenneck, C.; Foelster-Holst, R.; Hagemann, T.
  • Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting
    Schmitt, J.; Spuls, P.; Boers, M.
  • Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation
    Schmitt, J.; Langan, S.; Deckert, S.
  • Willingness to pay and quality of life in patients with atopic dermatitis
    Beikert, F.C.; Langenbruch, A.K.; Radtke, M.A.
  • Impact of atopic skin diathesis on occupational skin disease incidence in a working population
    Dickel, H.; Bruckner, T.M.; Schmidt, A.
  • Leitlinie zur (allergen-) spezifischen Immuntherapie bei IgE-vermittelten allergischen Erkrankungen
    Pfaar, O.; Bachert, C.; Bufe, A.; Buhl, R.; Ebner, C.
  • Cyclosporine therapy in dermatology
    Mrowietz, U.; Klein, C.E.; Reich, K.
  • Dupilumab treatment in adults with moderate-to- severe atopic dermatitis
    Beck, L.A.; Thaci, D.; Hamilton, J.D.